Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Siv Venkat"'
Autor:
Patrick Lewicki, Camilo Arenas-Gallo, Spyridon P. Basourakos, Nahid Punjani, Siv Venkat, Douglas S. Scherr, Jim C. Hu, Jonathan E. Shoag
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveTo analyze population-level changes in operative practice since the onset of the COVID-19 pandemic to contextualize observations made by individual practices and optimize future responses.Materials and MethodsThis US retrospective analysis u
Externí odkaz:
https://doaj.org/article/fb7df2455f3b4a4a975fe305f8b30cdb
Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer
Autor:
Spyridon P. Basourakos, Michael Tzeng, Patrick J. Lewicki, Krishnan Patel, Bashir Al Hussein Al Awamlh, Siv Venkat, Jonathan E. Shoag, Michael A. Gorin, Christopher E. Barbieri, Jim C. Hu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Risk stratification of men with clinically localized prostate cancer has historically relied on basic clinicopathologic parameters such as prostate specific antigen level, grade group, and clinical stage. However, prostate cancer often behaves in way
Externí odkaz:
https://doaj.org/article/d7726c9948824e49a6d9c64a424665b7
Publikováno v:
Case Reports in Urology, Vol 2019 (2019)
The thoracoabdominal incision was first described in 1946 as an approach to concomitant abdominal, retroperitoneal, and thoracic injuries. In urology, this technique was popularized in 1949 for the resection of large renal tumours. Today, it is reser
Externí odkaz:
https://doaj.org/article/4f05ca73a1c540f598a5a71b93f9a8f9
Autor:
Siv Venkat, Camilo Arenas-Gallo, Patrick Lewicki, Yuqing Qiu, Spyridon P. Basourakos, Jonathan E. Shoag, Douglas S. Scherr
Publikováno v:
European Urology Focus. 8:968-971
Blue light cystoscopy (BLC) during transurethral resection of bladder tumor (TURBT) is guideline-recommended as it improves cancer detection and decreases recurrence of the disease. However, the extent to which BLC is used has not been established. W
Autor:
Siv Venkat, Patrick J. Lewicki, Aleem I. Khan, Chris Gaffney, Leonardo Borregales, Douglas S. Scherr
Publikováno v:
Clinical Genitourinary Cancer. 20:e140-e150
We sought to evaluate sociodemographic disparities in access to neoadjuvant (NAC) and adjuvant (AC) chemotherapy in the United States and their effect on survival.The National Cancer Database was used to identify all patients from 2004 to 2016 eligib
Impact of Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Population Based Analysis
Publikováno v:
Bladder Cancer. 7:401-412
BACKGROUND AND OBJECTIVES: We examined pathologic complete response (pCR) and pathologic downstaging (pDS) rates after neoadjuvant chemotherapy (NAC) in high-risk upper tract urothelial carcinoma, as well as their predictors. We further sought to det
Autor:
Patrick Lewicki, Camilo Arenas Gallo, Spyridon P. Basourakos, Nahid Punjani, Bashir Al Hussein Al Awamlh, Siv Venkat, Douglas S. Scherr, Jim C. Hu, Jonathan E. Shoag
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:While subject to frequent speculation, the actual impact of the COVID-19 pandemic on urologic operative practice is unknown. Understanding the consequences of the pandemi...
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Lymph node (LN) dissection (LND) in high-risk upper tract urothelial carcinoma (UTUC) currently remains underperformed compared to other cancers, partly due to a lack of ...
Publikováno v:
Journal of Urology. 206
Autor:
Patrick Lewicki, Camilo Arenas-Gallo, Spyridon P. Basourakos, Bashir Al Hussein Al Awamlh, Siv Venkat, Douglas S. Scherr, Jonathan E. Shoag
Publikováno v:
Urology. 156